First American Financial just delivered Q3 2026 numbers that looked solid on paper, yet the stock barely flinched. Shares sit around US$64.72, slightly below last close and down over the past three months, even as trailing 12 month earnings reach about US$7.13 per share on roughly US$8.09b of revenue.
The real story is the valuation strain. The insurer trades on a single digit P/E while its share price sits well above one discounted cash flow estimate. In the short term, the market reaction feels muted. Over a longer horizon, investors are weighing that gap between price, earnings power and modeled intrinsic value.
Like the earnings profile at First American Financial but uneasy about paying up for a stock that screens as cheap on a P/E while one cash flow model flags a valuation gap? Benchmark this setup against a curated list of solid balance sheet and fundamentals stocks by checking our list of solid balance sheet and fundamentals stocks (24 results) .
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs. Q3 2025):US$2,084.6m vs. US$1,978.9m (up about 5.3%)
-
Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025):US$177.0m vs. US$189.6m (down about 6.6%)
-
Basic EPS (Q3 2026 vs. Q3 2025):US$1.72 vs. US$1.84 (down about 6.6%)
-
Trailing 12 Month Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025):US$732.5m vs. US$482.3m (up about 51.9%)
Endpoint and Sequoia are taking over more of First American's orders. Ask Charlie what's really behind First American's automation push .
First American bullish thesis meets mixed execution
The upbeat view hinges on automation lifting First American Financial's structural profitability, not just surviving a slow housing cycle.
"Accelerating adoption and rollout of proprietary technology platforms such as Endpoint and Sequoia has progressed, with automation now covering a rising share of escrow tasks and title decisioning and with management targeting broad branch and national deployment by 2027."
Q3 progress backs this up. Endpoint automation improved to 42% from 30% in Q1, and Sequoia cut purchase human review time to 56 minutes. Title revenue rose faster than group revenue; however, pretax margins are guided as stable to slightly pressured, so the hoped for margin step up is not visible yet.
Bear case on housing and concentration still visible
The more cautious narrative centers on residential drag and reliance on chunky commercial deals.
"Persistent home affordability issues and elevated mortgage rates have led to continued weakness in residential real estate transactions, with recent data showing purchase revenue still soft and closed purchase orders declining."
Q3 confirms that risk. Purchase revenue fell 3% and refinance revenue slipped 1%, with refi only about 5% of direct title revenue. Early October open orders show further declines in purchase and refinance activity, and management expects residential volumes to stay pressured into 2027. Strong commercial revenue, up 21%, is helping offset the weakness but also increases dependence on large transactions.
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for .
Hunt For Quietly Mispriced Compounds
First American Financial recently highlighted how share prices and earnings strength can move differently. The real opportunity could sit in stocks that seem misaligned before the market potentially reassesses them.
-
Company 1 - 42% below our estimate - sells large LED systems into transportation and sports projects as customers connect displays with software-driven networks.
-
Company 2 - 22% below our estimate - uses surgical robotics and data tools to deepen procedure coverage as hospitals align onto one orthopaedic platform.
-
Company 3 - 31% below our estimate - supplies custom chips and connectivity hardware that hyperscalers adopt to manage expanding data traffic and security workloads.
Three companies from the same screener. Open all 29 potentially undervalued companies →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include FAF .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
